ArticleTherapeutic advances in drug safety2015

hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.

Jules C Hancox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.